Cargando…
Physicians’ Knowledge, Attitude, and Experience of Pharmacogenomic Testing in China
(1) Background: As prescribers, physicians play a decisive role in applying and promoting pharmacogenomic (PGx) testing in clinical practices. So far, little is known about physicians’ perspectives on PGx testing in China. The aim of this study was to assess physicians’ knowledge of, attitude toward...
Autores principales: | Jia, Tong, Wu, Caiying, Hu, Xiaowen, Li, Sicong, Zhang, Xinyi, Cai, Yuchun, Chen, Jing, Shi, Luwen, Lu, Christine Y., Nie, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783535/ https://www.ncbi.nlm.nih.gov/pubmed/36556242 http://dx.doi.org/10.3390/jpm12122021 |
Ejemplares similares
-
Clinical Pharmacists’ Knowledge of and Attitudes toward Pharmacogenomic Testing in China
por: Nie, Xiaoyan, et al.
Publicado: (2022) -
Clinical Pharmacists’ Involvement in Pharmacogenomics Testing and Related Services in China
por: Hu, Xiaowen, et al.
Publicado: (2022) -
Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis
por: Zhao, Yuxuan, et al.
Publicado: (2022) -
Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis
por: Li, Sicong, et al.
Publicado: (2022) -
Personal genome testing on physicians improves attitudes on pharmacogenomic approaches
por: Lee, Kye Hwa, et al.
Publicado: (2019)